Cargando…

Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways

Preeclampsia, a hypertensive disorder occurring during pregnancy, is characterized by excessive oxidative stress and trophoblast dysfunction with dysregulation of soluble Fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) production. Nicotinamide Adenine Dinucleotide Phosphate (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Isabelle, Chissey, Audrey, Guibourdenche, Jean, Atasoy, Roger, Coumoul, Xavier, Fournier, Thierry, Beaudeux, Jean-Louis, Zerrad-Saadi, Amal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918586/
https://www.ncbi.nlm.nih.gov/pubmed/33673360
http://dx.doi.org/10.3390/antiox10020281
_version_ 1783657957114773504
author Hernandez, Isabelle
Chissey, Audrey
Guibourdenche, Jean
Atasoy, Roger
Coumoul, Xavier
Fournier, Thierry
Beaudeux, Jean-Louis
Zerrad-Saadi, Amal
author_facet Hernandez, Isabelle
Chissey, Audrey
Guibourdenche, Jean
Atasoy, Roger
Coumoul, Xavier
Fournier, Thierry
Beaudeux, Jean-Louis
Zerrad-Saadi, Amal
author_sort Hernandez, Isabelle
collection PubMed
description Preeclampsia, a hypertensive disorder occurring during pregnancy, is characterized by excessive oxidative stress and trophoblast dysfunction with dysregulation of soluble Fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) production. Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase (Nox) is the major source of placental superoxide in early pregnancy and its activation with the subsequent formation of superoxide has been demonstrated for various agents including Transforming Growth Factor beta-1 (TGF-β1), a well-known p38 MAPK pathway activator. However, the bridge between Nox and sFlt-1 remains unknown. The purpose of this study was to explore the possible signaling pathway of TGF-β1/Nox/p38 induced sFlt-1 production in human chorionic villi (CV). Methods: Human chorionic villi from first trimester placenta (7–9 Gestational Weeks (GW)) were treated with TGF-β1 or preincubated with p38 inhibitor, SB203580. For NADPH oxidase inhibition, CV were treated with diphenyleneiodonium (DPI). The protein levels of phospho-p38, p38, phospho-Mothers Against Decapentaplegic homolog 2 (SMAD2), and SMAD2 were detected by Western blot. The secretion of sFlt-1 and PlGF by chorionic villi were measured with Electrochemiluminescence Immunologic Assays, and NADPH oxidase activity was monitored by lucigenin method. Results: We demonstrate for the first time that NADPH oxidase is involved in sFlt-1 and PlGF secretion in first trimester chorionic villi. Indeed, the inhibition of Nox by DPI decreases sFlt-1, and increases PlGF secretions. We also demonstrate the involvement of p38 MAPK in sFlt-1 secretion and Nox activation as blocking the p38 MAPK phosphorylation decreases both sFlt-1 secretion and superoxide production. Nevertheless, TGF-β1-mediated p38 activation do not seem to be involved in regulation of the first trimester placental angiogenic balance and no crosstalk was found between SMAD2 and p38 MAPK pathways. Conclusions: Thus, the placental NADPH oxidase play a major role in mediating the signal transduction cascade of sFlt-1 production. Furthermore, we highlight for the first time the involvement of p38 activation in first trimester placental Nox activity.
format Online
Article
Text
id pubmed-7918586
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79185862021-03-02 Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways Hernandez, Isabelle Chissey, Audrey Guibourdenche, Jean Atasoy, Roger Coumoul, Xavier Fournier, Thierry Beaudeux, Jean-Louis Zerrad-Saadi, Amal Antioxidants (Basel) Article Preeclampsia, a hypertensive disorder occurring during pregnancy, is characterized by excessive oxidative stress and trophoblast dysfunction with dysregulation of soluble Fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) production. Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase (Nox) is the major source of placental superoxide in early pregnancy and its activation with the subsequent formation of superoxide has been demonstrated for various agents including Transforming Growth Factor beta-1 (TGF-β1), a well-known p38 MAPK pathway activator. However, the bridge between Nox and sFlt-1 remains unknown. The purpose of this study was to explore the possible signaling pathway of TGF-β1/Nox/p38 induced sFlt-1 production in human chorionic villi (CV). Methods: Human chorionic villi from first trimester placenta (7–9 Gestational Weeks (GW)) were treated with TGF-β1 or preincubated with p38 inhibitor, SB203580. For NADPH oxidase inhibition, CV were treated with diphenyleneiodonium (DPI). The protein levels of phospho-p38, p38, phospho-Mothers Against Decapentaplegic homolog 2 (SMAD2), and SMAD2 were detected by Western blot. The secretion of sFlt-1 and PlGF by chorionic villi were measured with Electrochemiluminescence Immunologic Assays, and NADPH oxidase activity was monitored by lucigenin method. Results: We demonstrate for the first time that NADPH oxidase is involved in sFlt-1 and PlGF secretion in first trimester chorionic villi. Indeed, the inhibition of Nox by DPI decreases sFlt-1, and increases PlGF secretions. We also demonstrate the involvement of p38 MAPK in sFlt-1 secretion and Nox activation as blocking the p38 MAPK phosphorylation decreases both sFlt-1 secretion and superoxide production. Nevertheless, TGF-β1-mediated p38 activation do not seem to be involved in regulation of the first trimester placental angiogenic balance and no crosstalk was found between SMAD2 and p38 MAPK pathways. Conclusions: Thus, the placental NADPH oxidase play a major role in mediating the signal transduction cascade of sFlt-1 production. Furthermore, we highlight for the first time the involvement of p38 activation in first trimester placental Nox activity. MDPI 2021-02-12 /pmc/articles/PMC7918586/ /pubmed/33673360 http://dx.doi.org/10.3390/antiox10020281 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hernandez, Isabelle
Chissey, Audrey
Guibourdenche, Jean
Atasoy, Roger
Coumoul, Xavier
Fournier, Thierry
Beaudeux, Jean-Louis
Zerrad-Saadi, Amal
Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
title Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
title_full Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
title_fullStr Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
title_full_unstemmed Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
title_short Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
title_sort human placental nadph oxidase mediates sflt-1 and plgf secretion in early pregnancy: exploration of the tgf-β1/p38 mapk pathways
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918586/
https://www.ncbi.nlm.nih.gov/pubmed/33673360
http://dx.doi.org/10.3390/antiox10020281
work_keys_str_mv AT hernandezisabelle humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways
AT chisseyaudrey humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways
AT guibourdenchejean humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways
AT atasoyroger humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways
AT coumoulxavier humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways
AT fournierthierry humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways
AT beaudeuxjeanlouis humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways
AT zerradsaadiamal humanplacentalnadphoxidasemediatessflt1andplgfsecretioninearlypregnancyexplorationofthetgfb1p38mapkpathways